Navigation Links
STIX Market Research Celebrates Ten Years of Technology/Market Analysis, Custom Research, and Niche Publishing; Prepares New Growth Phase
Date:4/25/2009

dy, even remarkable market growth don't want to see a period of declining unit sales and falling value. When that is the situation, this is just the kind of intelligence that they need." STIX can fill that need and will respond to requests for proposals or prepare introductory briefing packages on a variety of topics.

STIX uses a combination of primary and secondary research methods as needed. "Our methodology relies on an experienced team, a structured research technique, and access to proprietary market modeling approaches and algorithms held in the STIX library and archives," says Ms. Crull. "For or custom research projects, we field an experienced team with more than fifty years of experience in comprehensive market/technology/industry analysis in a variety of areas. Each team member has an extensive academic background; broad industry experience; continuous involvement in the forefront of technology developments through hands-on work, professional and technical organizations; and continuous contacts with key multi-national companies that are in the forefront of bringing new products to market. In addition, the core team has access to an established network of subject matter experts (SMEs) in industry, government, and academia. These SMEs will be used to help validate project scope, as content sources, and to validate deliverable assumptions."

"Send us your RFPs," says Saxman. You'll be pleasantly surprised by what we can offer you in terms of methodology, expertise, pricing and flexibility."

About STIX
STIX is a consulting and information evaluation organization of experts with experience in advanced technology market analysis and identification of business opportunities. The variety of disciplines in the STIX play book include energy, batteries, fuel cells, advanced materials, nanotechnology, alternative fuels, and transportation, military technology, music downloads, combination drugs,
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
2. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
4. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
5. Sodexho, Inc. Announces Patrick E. Connolly as Market President & COO
6. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Paramount Acquisition Corp. Announces Chem Rx Expansion into Albany, New York Market
9. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
10. Ranbaxy Gains Approval to Manufacture and Market Carvedilol Tablets in the U.S. Market
11. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... (PRWEB) July 31, 2014 A ... Heart Specialists is helping patients who have an ... is used for ablation procedures for patients such ... electrophysiologists at Baptist Heart Specialists were the ... new catheter this past spring, according to Biosense ...
(Date:7/31/2014)... dentist isn,t fun for anyone, but for those with periodontal ... may have them smiling. In a report appearing in the ... Biology , one of the most important blood cells ... to promote inflammation and bone loss in type 2 diabetes-associated ... that manipulate the responses of B cells may treat or ...
(Date:7/31/2014)... July 31, 2014 Bedros Keuilian’s Fit Body ... in several other countries. At his annual Fitness Business Summits, ... Keuilian for their marketing strategies. But in his latest blog ... for marketing a personal training business is to ... “Almost every personal trainer has a certain area that they ...
(Date:7/31/2014)... Quincy Bioscience, a fast-growing biotech company in Madison, ... the second edition of the Making Memories e-booklet series ... of a Grandchild. , The Prevagen-sponsored e-book is ... ideas for grandparents to utilize during the precious moments ... published in the e-book is free or low-cost to ...
(Date:7/31/2014)... 2014 FORT LAUDERDALE, FLORIDA – ... leading US Joint Commission Accredited teleradiology and telemedicine ... technologically advanced consumer storage and sharing platform for ... providing valued members the use of its Cloud-based ... already offered by SecondOpinions.com®. , Wide-spread radiologic ...
Breaking Medicine News(10 mins):Health News:New Catheter Improves Outcomes for Abnormal Heart Beat 2Health News:New Catheter Improves Outcomes for Abnormal Heart Beat 3Health News:Researchers uncover cause of gum disease related to type 2 diabetes 2Health News:Bedros Keuilian’s New Post Explains the Value of Fitness Information Products in Marketing a Personal Training Business 2Health News:Bedros Keuilian’s New Post Explains the Value of Fitness Information Products in Marketing a Personal Training Business 3Health News:Quincy Bioscience Launches the Second E-Book of the Making Memories Series 2Health News:SECONDOPINIONS.COM® Introduces Innovative Cloud-Based Medical Imaging Exchange Service for Easy Upload, Access and Sharing Anytime/Anywhere 2Health News:SECONDOPINIONS.COM® Introduces Innovative Cloud-Based Medical Imaging Exchange Service for Easy Upload, Access and Sharing Anytime/Anywhere 3
... Mothers, exposure during pregnancy to a class of air ... problems in their children. PAH are,released to air during ... coal, and other,organic material. , The study is the ... problems among school‐age children and two complementary measures of ...
... 21 (HealthDay News) -- Alzheimer,s disease and other types of ... brain, new research indicates. The findings from MRI brain ... to use MRI to predict the progression of dementias and ... San Francisco (UCSF) researchers said. They found that Alzheimer,s ...
... HealthDay Reporter , WEDNESDAY, March 21 (HealthDay ... treatments, alternative therapies such as acupuncture, acupressure and dietary ... sinusitis, a new pilot study suggests. The authors ... explore the potential of combining Western medicine with Eastern ...
... By Amanda Gardner HealthDay Reporter , WEDNESDAY, ... epidemic to the United States and the economic value of ... to a new report. The problem is that estimates ... out only 10 years, while it may take much longer ...
... HealthDay Reporter , WEDNESDAY, March 21 (HealthDay News) ... in people already taking statins such as Lipitor, making ... alternative, a preliminary new study suggests. Two single-dose ... a group with high cholesterol showed that the drug, ...
... led by A. K. Rajasekaran, PhD, Director of the Nemours ... protein involved in cell function and regulation is stopped by ... published online in the American Journal of Physiology - ... is well recognized as a cause of lung cancer and ...
Cached Medicine News:Health News:Prenatal exposure to combustion-related pollutants and anxiety, attention problems in young children 2Health News:Alternative Medicine May Help Ease Chronic Sinusitis 2Health News:Alternative Medicine May Help Ease Chronic Sinusitis 3Health News:U.S. Underestimates Long-Term Costs of Obesity, Experts Say 2Health News:U.S. Underestimates Long-Term Costs of Obesity, Experts Say 3Health News:Statin Alternative Looks Promising in Early Trials 2Health News:Statin Alternative Looks Promising in Early Trials 3Health News:Nemours researchers uncover new evidence of cancer-causing agent present in gaseous phase of cigarette smoke 2
(Date:7/31/2014)... , July 31, 2014  Celsion Corporation (NASDAQ: ... host a conference call to discuss its second quarter ... August 7, 2014. To participate in the call, interested ... ) or 1-785-830-1924 (International/Toll) and ask for the Celsion ... to register ten minutes before the call is scheduled ...
(Date:7/31/2014)... 2014 Endo International plc (NASDAQ: ... revenues of $719 million, an increase of 1 percent ... Endo reported net income of $21 million in the ... million in the second quarter of 2013.  As detailed ... for the three months ended June 30, 2014 increased by ...
(Date:7/31/2014)... , July 31, 2014 ... ), a specialty biopharmaceutical company, today announced that ... milestone payment from its partner Asahi Kasei Pharma ... of the successful submission of a regulatory application ... (PMDA) for XIAFLEX ® (collagenase clostridium histolyticum) ...
Breaking Medicine Technology:Celsion Corporation to Hold Second Quarter 2014 Financial Results 2Endo Reports Second Quarter Financial Results 2Endo Reports Second Quarter Financial Results 3Endo Reports Second Quarter Financial Results 4Endo Reports Second Quarter Financial Results 5Endo Reports Second Quarter Financial Results 6Endo Reports Second Quarter Financial Results 7Endo Reports Second Quarter Financial Results 8Endo Reports Second Quarter Financial Results 9Endo Reports Second Quarter Financial Results 10Endo Reports Second Quarter Financial Results 11Endo Reports Second Quarter Financial Results 12Endo Reports Second Quarter Financial Results 13Endo Reports Second Quarter Financial Results 14Endo Reports Second Quarter Financial Results 15Endo Reports Second Quarter Financial Results 16Endo Reports Second Quarter Financial Results 17Endo Reports Second Quarter Financial Results 18Endo Reports Second Quarter Financial Results 19Endo Reports Second Quarter Financial Results 20Endo Reports Second Quarter Financial Results 21Endo Reports Second Quarter Financial Results 22Endo Reports Second Quarter Financial Results 23Endo Reports Second Quarter Financial Results 24Endo Reports Second Quarter Financial Results 25Endo Reports Second Quarter Financial Results 26Endo Reports Second Quarter Financial Results 27Endo Reports Second Quarter Financial Results 28Endo Reports Second Quarter Financial Results 29Endo Reports Second Quarter Financial Results 30Endo Reports Second Quarter Financial Results 31Endo Reports Second Quarter Financial Results 32Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 2Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 3Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 4
... Inc. (Nasdaq: ONXX ) today announced the ... proteasome inhibitor, at the American Society of Hematology (ASH) ... Convention Center in Orlando, FL. "The ... treatment option for patients with multiple myeloma, and we ...
... 2010 Decision Resources, one of the world,s leading research ... the acute ischemic stroke (AIS) drug market will remain relatively ... million in 2019 in the United States, France, Germany, Italy, ... 2010 findings from the topic entitled Acute Ischemic Stroke ...
Cached Medicine Technology:Onyx Pharmaceuticals Announces Data Presentations Highlighting Carfilzomib Development Program at 52nd American Society of Hematology Annual Meeting 2Onyx Pharmaceuticals Announces Data Presentations Highlighting Carfilzomib Development Program at 52nd American Society of Hematology Annual Meeting 3Onyx Pharmaceuticals Announces Data Presentations Highlighting Carfilzomib Development Program at 52nd American Society of Hematology Annual Meeting 4Onyx Pharmaceuticals Announces Data Presentations Highlighting Carfilzomib Development Program at 52nd American Society of Hematology Annual Meeting 5The Acute Ischemic Stroke Drug Market Will Remain Relatively Flat, Increasing from $460 Million in 2009 to Approximately $610 Million in 2019 2The Acute Ischemic Stroke Drug Market Will Remain Relatively Flat, Increasing from $460 Million in 2009 to Approximately $610 Million in 2019 3
... delicate urethral tissues. The gentle, ... provide nearly friction-free movement, without ... to maintain sterility. You simply ... own sterile water, avoiding contamination ...
The Antibacterial Personal Catheter® features a unique silicone composition that provides an antibacterial coated soft outer layer of silicone combined with a firm inner layer....
The Antibacterial Personal Catheter® features a unique silicone composition that provides an antibacterial coated soft outer layer of silicone combined with a firm inner layer....
... Rochester Medical's line of ... intermittent catheters you would ... four product configurations - ... antibacterial hydro - are ...
Medicine Products: